Table 3.
Past-Year Nonmedical Use of Prescription Opioids at Age 35 | Alcohol Use Disorder Symptoms at Age 35 | Marijuana Use Disorder Symptoms at Age 35 | Other Drug Use Disorder Symptoms at Age 35 | Any Substance Use Disorder Symptoms at Age 35 | |
---|---|---|---|---|---|
Baseline Context of Exposure to Prescription Opioids (Age 18) | 1AOR (95% CI) | 2+ Symptoms 1AOR (95% CI) |
2+ Symptoms 1AOR (95% CI) |
2+ Symptoms 1AOR (95% CI) |
2+ Symptoms 1AOR (95% CI) |
| |||||
No medical or nonmedical use (n = 3,014) | Reference | Reference | Reference | Reference | Reference |
Medical use only (n = 527) | 1.74 (1.10, 2.76)* | 1.05 (.855, 1.31) | 1.04 (.694, 1.57) | 1.17 (.717, 1.92) | 1.13 (.914, 1.40) |
Medical and nonmedical use (n = 207) | 3.22 (1.93, 5.36)*** | 1.35 (1.03, 1.77)* | 1.42 (.944, 2.15) | 3.07 (1.93, 4.88)*** | 1.49 (1.13, 1.97)** |
Nonmedical use only (n = 116) | 2.09 (1.10, 3.96)* | 2.04 (1.50, 2.79)*** | 2.73 (1.75, 4.26)*** | 4.39 (2.73, 7.06)*** | 2.61 (1.88, 3.61)*** |
| |||||
2Sample size | 2n = 3576 | 2n = 3768 | 2n = 3817 | 2n = 3631 | 2n = 3549 |
p<.05,
p<.01,
p<.001
All analyses control for race (i.e., White, Black, Hispanic, Other race), sex (i.e., Male and Female), geographic region (i.e., Northeast, Midwest, South and West), metropolitan statistical area (i.e., large MSA, other MSA, and non-MSA), parental education (college degree vs. no college degree) and cohort year at age 18. In addition, all models control for any substance use at baseline (i.e., annual alcohol use at age 18, annual marijuana use at age 18, and annual other drug use at age 18).
Sample sizes vary due to missing data on the dependent measures (i.e., substance use disorder symptoms at age 35).